These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11051383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Sacerdoti D, Felder M, Mazzaro C, Beltrame P, Gatta A.
    Lancet; ; 348(9043):1677-81. PubMed ID: 8973428
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C, Miñana J, Ortiz J, Gallego A, Soriano G, Torras X, Sáinz S, Boadas J, Cussó X, Guarner C, Balanzó J.
    N Engl J Med; 2001 Aug 30; 345(9):647-55. PubMed ID: 11547718
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy for secondary prophylaxis of variceal rebleeding?
    Maldonado D, Barkin JS.
    Am J Gastroenterol; 2002 Aug 30; 97(8):2134-6. PubMed ID: 12190191
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
    Borroni G, Salerno F, Cazzaniga M, Bissoli F, Lorenzano E, Maggi A, Visentin S, Panzeri A, de Franchis R.
    J Hepatol; 2002 Sep 30; 37(3):315-21. PubMed ID: 12175626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Bolognesi M, Felder M, Mazzaro C, Gatta A.
    Hepatology; 2000 Feb 30; 31(2):324-9. PubMed ID: 10655253
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C, Balanzó J, Novella MT, Soriano G, Sáinz S, Torras X, Cussó X, Guarner C, Vilardell F.
    N Engl J Med; 1996 Jun 20; 334(25):1624-9. PubMed ID: 8628357
    [Abstract] [Full Text] [Related]

  • 11. [Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
    Wiest R, Lock G, Messmann H.
    Z Gastroenterol; 2002 Jul 20; 40(7):547-9. PubMed ID: 12122606
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK, Wadhawan M, Gupta R, Shahi H.
    Dig Dis Sci; 2005 Aug 20; 50(8):1538-47. PubMed ID: 16110851
    [Abstract] [Full Text] [Related]

  • 13. Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
    Wang HM, Lo GH, Chen WC, Tsai WL, Chan HH, Cheng LC, Hsu PI, Lai KH.
    J Chin Med Assoc; 2006 Oct 20; 69(10):453-60. PubMed ID: 17098669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Isosorbide-5-mononitrate (mono mac) in the prevention of bleeding from esophageal varicose veins in patients with liver cirrhosis].
    Abdurakhmanov DT.
    Klin Med (Mosk); 2001 Oct 20; 79(2):60-2. PubMed ID: 11419092
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W, Nevens F.
    Minerva Med; 2006 Aug 20; 97(4):325-45. PubMed ID: 17008837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
    García-Pagán JC, Morillas R, Bañares R, Albillos A, Villanueva C, Vila C, Genescà J, Jimenez M, Rodriguez M, Calleja JL, Balanzó J, García-Durán F, Planas R, Bosch J, Spanish Variceal Bleeding Study Group.
    Hepatology; 2003 Jun 20; 37(6):1260-6. PubMed ID: 12774003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.